pharmacopeia
GET
/api/v1/drug/pheniramine

Mechanism of action

Sourced from openFDA

Mechanism-of-action class: Histamine H1 Receptor Antagonists.

Histamine H1 Receptor

Indications

Sourced from openFDA
  • Uses Temporarily relieves itchy, red eyes due to: pollen ragweed grass animal hair and dander

Dosage & administration

Sourced from openFDA

Directions adults and children 6 years of age and over: put 1 or 2 drops in the affected eye(s) up to 4 times a day children under 6 years of age: consult a doctor

Warnings & precautions

Sourced from openFDA

For external use only Do not use if you are sensitive to any ingredient in this product. Ask a doctor before use if you have heart disease high blood pressure narrow angle glaucoma trouble urinating When using this product pupils may become enlarged temporarily causing light sensitivity do not touch tip of container to any surface to avoid contamination replace cap after each use remove contact lenses before using do not use if this solution changes color or becomes cloudy overuse may cause more eye redness some users may experience a brief tingling sensation Stop use and ask a doctor if you feel eye pain changes in vision occur redness or irritation of the eye lasts condition worsens or lasts more than 72 hours Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away. Accidental swallowing by infants and children may lead to coma and marked reduction in body temperature.

Approval history

Sourced from openFDA
  • Jun 8, 1994NDANDA020226Alcon
  • Jun 8, 1994NDANDA020065Bausch And Lomb
  • Jan 31, 1996NDANDA020485Kenvue Brands
  • Sep 27, 2010ANDAANDA078208Altaire Pharms Inc

FAERS reports

View JSON
Reference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. Counts reflect reporting volume — how often a reaction was reported, not how often it occurs. For decision-grade use, consult openFDA and the FAERS Public Dashboard directly.
1,910 total reports matchedLatest report Share = reports listing the reaction ÷ total matched reports. Rows can sum to >100% because a single report often lists multiple reactions.
  1. 1Eye Irritation47425%
  2. 2Mydriasis46925%
  3. 3Drug Ineffective32217%
  4. 4Vision Blurred22312%
  5. 5Eye Pain1839.6%
  6. 6Ocular Hyperaemia1628.5%
  7. 7Instillation Site Pain1045.4%
  8. 8Condition Aggravated743.9%
  9. 9Eye Pruritus723.8%
  10. 10Lacrimation Increased673.5%
  11. 11Eye Swelling502.6%
  12. 12Headache482.5%
  13. 13Product Quality Issue472.5%
  14. 14Dry Eye452.4%
  15. 15Visual Impairment452.4%

Literature

View JSON

Recent PubMed references pinned to Pheniramine as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.

Clinical trials

View JSON

The 10 most recently updated of 30 ClinicalTrials.gov registrations naming Pheniramine as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.

Frequently asked questions

How does Pheniramine work?
Mechanism-of-action class: Histamine H1 Receptor Antagonists.
What is Pheniramine used for?
According to FDA labeling, Pheniramine carries indications including: Uses Temporarily relieves itchy, red eyes due to: pollen ragweed grass animal hair and dander. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.
What class of drug is Pheniramine?
Pheniramine is classified as Antihistamines for topical use, Substituted alkylamines, Histamine H1 Receptor Antagonists, Decreased Histamine Activity.
What are the brand names for Pheniramine?
Pheniramine is marketed under brand names including Alahist D, Naphcon A, Opcon-A.
Note. Data for pheniramine is illustrative MVP content compiled from public sources. pharmacopeia is for educational and informational use only and is not a substitute for professional medical advice.

Search pharmacopeia

Search drugs, classes, and ingredients